scispace - formally typeset
S

Sara Brett

Researcher at GlaxoSmithKline

Publications -  31
Citations -  2158

Sara Brett is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: T cell & Cytotoxic T cell. The author has an hindex of 15, co-authored 27 publications receiving 1921 citations.

Papers
More filters
Journal ArticleDOI

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming.

TL;DR: It is shown in mice that natural killer (NK) cells are rapidly recruited in a CCR7-independent, CXCR3-dependent manner to lymph nodes on stimulation by the injection of mature DCs, and an induced pathway of NK cell migration in antigen-stimulated lymph nodes is identified.
Journal ArticleDOI

Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e‐antigen seroconversion

TL;DR: It is demonstrated that in chronic HBV infection, both viremia levels and HBeAg drive PD‐1 expression and resulting T‐cell impairment, and additional immunotherapeutic interventions are needed for restoration of T‐ cell functions.
Journal ArticleDOI

Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.

TL;DR: Two studies in mice suggest that both imiquimod and resquimod may be suitable adjuvants for therapeutic DNA vaccines requiring induction of potent cytotoxic T cell responses.
Journal ArticleDOI

Lipoprotein Access to MHC Class I Presentation During Infection of Murine Macrophages with Live Mycobacteria

TL;DR: Preliminary experiments suggest that class I presentation is more efficient during infection with rapid-growing mycobacteria than with the slow-growing bacillus Calmette-Guérin vaccine strain.